Privia Health stock: Q3 growth lifts 2026 outlook

Privia Health Group raised its full-year 2026 outlook on November 5 after reporting stronger third-quarter results and announcing an expansion of its value-based care network. The company said in its official release that revenue rose 13.2 percent year over year to USD 657.0 million for the three months ended September 30, 2026.

Results support higher 2026 targets

Operating income increased 42.6 percent to USD 20.5 million, while net income attributable to Privia Health reached USD 13.5 million, compared with USD 6.9 million a year earlier. Adjusted net income per diluted share rose to USD 0.21 from USD 0.19. The company said net income included USD 14.0 million in non-cash stock compensation expense, making the adjusted figures relevant when assessing operating performance.

For the first nine months, revenue rose 19.7 percent to USD 1.89 billion and net income increased 85.9 percent to USD 25.6 million. Adjusted EBITDA advanced 21.9 percent to USD 114.7 million, equal to 28.8 percent of care margin.

Acquisition expands Medicare reach

Privia agreed to acquire American Choice Healthcare MSSP, a wholly owned subsidiary of Cano Health, for approximately USD 36 million in cash. The accountable care organization is expected to serve more than 36,000 attributed lives in the Medicare Shared Savings Program beginning January 1, 2027. The transaction adds lives in three new states and expands Privia's presence in ten existing states.

Privia said the acquisition should have minimal impact on 2026 results but contribute positively to attributed lives and adjusted EBITDA in 2027. The company also agreed to end its Montana partnership with Surgery Partners in January 2027, covering 69 providers and approximately USD 23 million in annual practice collections.

National platform faces varied rivals

Privia Health is a US physician enablement company that supports independent medical groups with technology, practice services, value-based care arrangements and population-health tools. The company says it operates in 25 states and the District of Columbia, supports about 1,400 physician practices and serves more than 6.3 million patients. In the value-based care enablement market, Astute Analytica lists Privia alongside Aledade, agilon health and Evolent Health; Aledade is more focused on shared savings, agilon on primary-care risk partnerships and Evolent on specialty and complex care.

US healthcare shares remain sensitive to reimbursement policy, provider costs and expectations for value-based care adoption; investors can follow the S&P 500 for the broader market backdrop.

More news and analyses on Privia Health stock.